Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167125 | SCV000217955 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000205195 | SCV000259725 | likely benign | Familial cancer of breast | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000205195 | SCV000487945 | likely benign | Familial cancer of breast | 2015-12-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721087 | SCV000566476 | likely benign | not provided | 2018-05-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000167125 | SCV000906503 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002485038 | SCV002799278 | likely benign | Familial cancer of breast; Fanconi anemia complementation group N; Pancreatic cancer, susceptibility to, 3 | 2022-02-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000205195 | SCV004019123 | benign | Familial cancer of breast | 2023-03-30 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004535134 | SCV004712762 | likely benign | PALB2-related disorder | 2023-08-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |